Physician

Abigail Marie O'Brien, FNP-C

According to 2025 Medicare claims, Abigail O'Brien, FNP-C (NPI: 1770295818) practices nurse practitioner in the Traverse City, MI market, with the plurality of this provider's patient population coming from Grand Traverse, MI. This provider's primary affiliated billing organization is CHRONIC CARE MANAGEMENT LLC (NPI: 1730506726; TIN: 465217360) and primary practice location at 49684-9998. O'Brien is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

O'Brien's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 61 traditional Medicare patients, billed 318 HCPCS/CPT codes, and received $23,821 in Medicare payments. The top billing code was 99350 (Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes). Part D data shows 2,337 prescription claims across 245 beneficiaries totaling $286,155 in drug costs, led by Austedo (Deutetrabenazine). Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$34K$69K2023 Medicare payment: $68,672 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $23,821 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023141875$68,672
202461318$23,821

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$143K$286K2023 Drug cost: $109,224 (USD; Tot_Drug_Cst)2024 Drug cost: $286,155 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20231772,243$109,224
20242452,337$286,155

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99350Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes47107$120
99349Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes4289$82
99497Advance care planning, first 30 minutes1115$53
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's3259$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
AustedoDeutetrabenazine37259$134,690
JardianceEmpagliflozin931,573$33,283
EliquisApixaban581,443$29,313
VraylarCariprazine Hcl12168$8,597
LamotrigineLamotrigine13390$2,624

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$15Mylan Specialty L.P.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abigail Marie O'Brien, FNP-C?

Tedicare shows public-source Medicare data for Abigail Marie O'Brien, FNP-C (NPI 1770295818), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abigail Marie O'Brien, FNP-C have ACO affiliation data?

Abigail Marie O'Brien, FNP-C is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626), Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220), and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Abigail Marie O'Brien, FNP-C?

Abigail Marie O'Brien, FNP-C is linked to CHRONIC CARE MANAGEMENT LLC (billing NPI 1730506726) in the available physician profile data.

Does Abigail Marie O'Brien, FNP-C have Open Payments data?

Abigail Marie O'Brien, FNP-C has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.